Novo A/S

is the holding company for the Novo Group

Click to learn more

Novo Seeds

Great ideas need nurture and know-how to grow strong

Novo Ventures

An active partner with an international platform and long-term commitment

Novo Growth Equity

Creating value by holding rather than by exiting

Novo Finance

Financial investments based on a clear investment philosophy

Novo press release

Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million.

Click here to read the press release.